Perturbations of Fibroblast Growth Factors 19 and 21 in Type 2 Diabetes

Stephen L. Roesch; Amanda M. Styer; G. Craig Wood; Zachary Kosak; Jamie Seiler; Peter Benotti; Anthony T. Petrick; Jon Gabrielsen; William E. Strodel; Glenn S. Gerhard; Christopher D. Still; George Argyropoulos

doi:10.1371/journal.pone.0116928

Loading metrics

Open Access

Peer-reviewed

Research Article

Perturbations of Fibroblast Growth Factors 19 and 21 in Type 2 Diabetes

Stephen L. Roesch,

Affiliation Institute of Obesity, Geisinger Health System, Danville, PA, United States of America
⨯
Amanda M. Styer,

Affiliation Institute of Obesity, Geisinger Health System, Danville, PA, United States of America
⨯
G. Craig Wood,

Affiliation Institute of Obesity, Geisinger Health System, Danville, PA, United States of America
⨯
Zachary Kosak,

Affiliation Institute of Obesity, Geisinger Health System, Danville, PA, United States of America
⨯
Jamie Seiler,

Affiliation Institute of Obesity, Geisinger Health System, Danville, PA, United States of America
⨯
Peter Benotti,

Affiliation Institute of Obesity, Geisinger Health System, Danville, PA, United States of America
⨯
Anthony T. Petrick,

Affiliation Department of Surgery, Geisinger Health System, Danville, PA, United States of America
⨯
Jon Gabrielsen,

Affiliation Department of Surgery, Geisinger Health System, Danville, PA, United States of America
⨯
William E. Strodel,

Affiliation Department of Surgery, Geisinger Health System, Danville, PA, United States of America
⨯
Glenn S. Gerhard,

Affiliations Institute of Obesity, Geisinger Health System, Danville, PA, United States of America, Department of Biochemistry and Molecular Biology and Department of Pathology and Laboratory Medicine, Pennsylvania State University, Hershey, PA, United States of America
⨯
Christopher D. Still,

Affiliation Institute of Obesity, Geisinger Health System, Danville, PA, United States of America
⨯
George Argyropoulos

* E-mail: gargyropoulos1@geisinger.edu

Affiliation Institute of Obesity, Geisinger Health System, Danville, PA, United States of America
⨯

Perturbations of Fibroblast Growth Factors 19 and 21 in Type 2 Diabetes

Stephen L. Roesch,
Amanda M. Styer,
G. Craig Wood,
Zachary Kosak,
Jamie Seiler,
Peter Benotti,
Anthony T. Petrick,
Jon Gabrielsen,
William E. Strodel,
Glenn S. Gerhard

Published: February 9, 2015
https://doi.org/10.1371/journal.pone.0116928

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Fibroblast growth factor
Is the Subject Area "Fibroblast growth factor" applicable to this article?

Thanks for your feedback.
Surgical and invasive medical procedures
Is the Subject Area "Surgical and invasive medical procedures" applicable to this article?

Thanks for your feedback.
Type 2 diabetes
Is the Subject Area "Type 2 diabetes" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Glucose
Is the Subject Area "Glucose" applicable to this article?

Thanks for your feedback.
Bile
Is the Subject Area "Bile" applicable to this article?

Thanks for your feedback.
Obesity
Is the Subject Area "Obesity" applicable to this article?

Thanks for your feedback.